INTRODUCTION
Luminescent probes play a crucial role in numerous bioapplications including bioimaging, biodetection, as well as disease diagnosis and therapeutics [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Currently, the visible emitting probes are widely used for in vitro studies. Nevertheless, their applications in vivo are limited by the strong absorption and scattering of visible lights in the biological media [11] [12] [13] . To circumvent these restrictions, luminescent probes exhibiting emission between 1,000 and 1,700 nm within the second near-infrared (NIR-II) region have been emerging in recent years since they can dramatically reduce scattering lights and increase penetration depth in biological applications, compared with those emitting in the visible or the first NIR (NIR-I, 750-1,000 nm) regions [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] .
To date, many advances have been made regarding the controlled synthesis, surface modification and optical properties of the NIR-II probes such as carbon nanotubes (CNTs) [32] [33] [34] [35] [36] , organic fluorophores [37] [38] [39] , semiconducting quantum dots (QDs) (e.g., PbSe and Ag 2 S) [40] [41] [42] and conjugated polymers [43] . However, CNTs usually exhibit broad emission bands (>300 nm) and low quantum yields (QY) (0.1-0.4%), which impedes their practical applications. For organic fluorophores, they may suffer from photobleaching and poor photostability. Besides, there are some unavoidable drawbacks for QDs such as photoblinking or intrinsic toxicity from the heavy metal elements (e.g., Pb and Cd). Conjugated polymers generally exhibit low solubility in aqueous solution. To these regards, it is of urgent demand to search for novel NIR-II luminescent nanoprobes to overcome the inherent limitations of the traditional ones.
Trivalent lanthanide ions (Ln 3+ ) have the electron configuration of 4f n 5s 2 5p
6 (n=1-13). Due to the rich energy levels of Ln 3+ , their emissions cover the spectrum region from ultraviolet, visible to NIR. As an alternative to the traditional NIR-II probes, Ln 3+ -doped nanoparticles (NPs) are particularly intriguing owing to their superior properties, including high stability against photobleaching, long-lived (μs-ms) luminescence for timegated detection, and narrow emission bands for multiplexed sensing [31, [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] ) were reported to produce NIR-II light (Fig. 1 ), but the NIR-II quantum yields (QYs) of most Ln 3+ -doped NPs were still too low to fulfill their practical application in luminescent biosensing. As such, continuous efforts were dedicated to developing highly efficient Ln 3+ -doped NIR-II luminescent nano-bioprobes. Although several classes of NIR-II luminescent probes like organic fluorophores, CNTs and QDs have already been well summarized in academic journals or books [58] [59] [60] [61] , a review focusing on Ln 3+ -based NIR-II nanoprobes is highly desired so far. Rather than being exhaustive, this review aims to present a comprehensive investigation about the most recent achievements in Ln 3+ -doped nano-bioprobes, which mainly covers from the strategies for improving the photoluminescence (PL) efficiency to their promising applications (Fig. 2) . We start by the design strategy of the highly efficient NIR-II NPs, with emphasis on host selection, cation incorporation and surface modification. We then highlight their key bioapplications such as bioimaging, bioassay and temperature sensing, respectively. Finally, emerging trends and further efforts are proposed.
DESIGN OF HIGHLY EFFICIENT NIR-II NANOPROBES
One of the bottlenecks for practical applications of NIR-II luminescent probes lies in their low QYs, which is defined as the ratio of the number of emitted photons to that of the absorbed photons. QYs of typical Ln 3+ -doped NIR-II NPs are summarized in Table 1 , which indicates that most of them show low PL efficiency. In order to achieve high NIR-II luminescence output for commercial applications, researchers proposed several strategies such as host selection, cation incorporation, and surface modification.
Host selection
The PL efficiency of Ln 3+ relies critically on the structure, crystal fields, local site symmetry and phonon energy of the host materials [45, 50] . Thus, the selection of hosts determines the optical properties of the Ln 3+ dopants.
Generally, desirable host materials should possess high optical damage threshold, low phonon energy, and close lattice matches to Ln 3+ dopants. Among these features, the phonon energy is a key parameter influencing their QYs. The host matrix with low energy phonons may suppress the multi-phonon relaxation process and reduce the non-radiative energy losses. This is important for Ln
3+
ions emitting in the NIR-II region, since the NIR-II emissions are easily quenched by high-energy vibrations [65] . (Fig. 3a) . By monitoring the emission of Er 3+ , the PL excitation spectrum was dominated by an intense and broad band centered at 300 nm that corresponds to the bandgap absorption of SnO 2 NPs (Fig. 3b) co-workers adopted the same strategy to improve the PL efficiency of CaF 2 :Nd NPs by co-doping with Y 3+ [63] . As a result, a high NIR-II QY of 9.30% was achieved, which was~3 times higher than that of CaF 2 :Nd NPs.
Surface modification
The deleterious surface quenching effect in the colloidal dispersions deriving from their high surface area-to-volume ratio of NPs strongly affects the QY of Ln 3+ -doped NPs. To minimize the PL quenching of emitters from the surface ligands and liquid media, designing high-quality core/shell structure is frequently used [93, 94] . For example, silica shell coating was adopted to suppress the vibrational quenching caused by the O-H groups [64, 95] . As a result, the NIR-II emission intensity of Ln 3+ dopants in the core NPs can be increased. Moreover, it was found that surface passivation by growing a uniform shell with similar lattice parameters was more efficient to improve the NIR-II QY of Ln 3+ -doped NPs. For instance, the NIR-II emission intensity of NaGdF 4 :Nd NPs was increased by 1.82 times after coating with a 2-nm NaGdF 4 shell [64] . The NIR-II QY of Nd 3+ in these NaGdF 4 :Nd@NaGdF 4 core/shell NPs was as high as 40%. Likewise, the NIR-II emission intensity of NaYF 4 :Yb/Nd core NPs was enhanced by 45 times after coating with the CaF 2 shell [68] . Recently, Alivisatos and co-workers [66] investigated the when the thickness of the shell was above~5 nm. Besides coating with an inorganic shell, surface modification with organic molecules (e.g., tropolonate, indocyanine green) was also adopted for the efficient NIR-II emission of Ln 3+ [70, 96] . As a typical example, indocyanine green (ICG) was coated on the surface of NaYF 4 :Yb/X@NaYbF 4 @NaYF 4 :Nd (X = Er, Ho, Tm, or Pr) NPs to increase their NIR-II emission intensity [70] .
In the ICG sensitized core-shell-shell (CSS) NPs, the energy transfer efficiency from ICG to the NPs was~75%. Meanwhile, their NIR-II QY was~13%. Note that the layer of organic molecule may passivate the surface of Ln 3+ -doped NPs and endow them with water solubility when they are transferred from a hydrophobic environment to hydrophilic one [8, 69, 73] . Such a feature is particularly important for NIR-II emissions of Ln 3+ which is sensitive to aqueous media due to small energy gap between their excited and ground states [45, 65] . To this end, several ligands like poly(acrylic acid) [73, 97] , polyethyleneimine [44] , poly(maleic anhydride-alt-1-octadecene)-polyethylene glycol (PMH-PEG) [67] were [102] compared the penetration depth between emission at 1,060 and 1,525 nm in bioimaging. It was found that the emission light of 1,525 nm showed higher penetration depth than that of 1,060 nm (Fig. 6a, b) . Subsequently, Diao et al. [23] also proposed that in vivo imaging based on emission beyond 1,500 nm afforded the high SNR and superior spatial resolution in bioimaging. The NaYbF 4 :Er/Ce@NaYF 4 NPs exhibiting 1,550 nm emission were employed for bioimaging of the blood vasculature in the hindlimb of mouse. The SNR of NIR-II bioimaging was determined to be 4.50, which is much higher than that of NIR-I bioimaging (i.e., 1.19). Meanwhile, a spatially resolved blood-flow map in the mouse brain can be captured in a very short exposure time (20 ms) (Fig. 6c-e ) [67] . Inspired by this work, NaYF 4 :Gd/Yb/Er nanorods were applied for bioimaging of tiny tumor (4 mm in diameter), by virtue of the highly efficient NIR-II emission at 1,520 nm of Er 3+ [73] .
Besides the emission wavelength, the selection of excitation wavelength is also of vital importance. Nowadays, the majority of Ln 3+ -doped NIR-II nanoprobes were excited at 980 nm, where Yb 3+ ions were used as sensitizer. [57] , NaYF 4 :Yb/Er/Mn [103] , to name a few. In one pioneering work, Naczynski et al. [46] demonstrated the application of NaYF 4 :Yb/Er NPs for in vivo NIR-II bioimaging upon excitation at 980 nm ( Fig. 6f-i) . Later, it was found that the excitation light of 980 nm might not be the ideal choice for bioimaging since the strong optical absorption of water at 980 nm may cause undesired tissue heating effect [104] . In this regard, the excitation at 740-800 nm with lower water absorption in tissue was proposed. -sensitized NPs (NaErF 4 :Ho@NaYF 4 ) with the excitation (1,530 nm) and emission (1,180 nm) located in NIR-II region. Nevertheless, the excitation at 1,530 nm locates in the strong absorption band of water, which may generate some overheating problems [106] . As such, X-rays instead of NIR light was proposed by Naczynski et al. [86] as excitation light to produce NIR-II emission of Er 3+ ions from NaYF 4 :Yb/Er NPs for lymphatic mapping (Fig. 7) . The use of X-rays may overcome the problem of the limited penetration depth of NIR excitation lights. In addition to the tuning of emission and excitation wavelength, lifetime manipulation also plays an important role in bioimaging. (Fig. 8a ). The one with shorter NIR-II PL lifetime was intruded in the mouse through oral administration and the other one with longer lifetime was intruded through intravenous injection. These two types of NPs can be distinguished from the lifetime imaging by a custom-made software. Correspondingly, their different biodistribution routes after oral or intravenous administration were clearly tracked and visualized (Fig. 8b) . By comparison, the biodistribution routes cannot be distinguished from intensity-based PL imaging (Fig. 8c) . Furthermore, Fan et al. [110] performed in vivo multiplexed imaging by employing Ln 3+ -doped NIR-II NPs with engineered PL lifetimes. They carried out cancer diagnostics in vivo with three kinds of core-shell NaGdF 4 @NaGdF 4 :Yb/Er@NaYF 4 :Yb@NaNdF 4 :Yb NPs (Er-NPs) of different lifetimes conjugated with primary antibodies, which were used for targeting three typical biomarkers of MCF-7 breast cancer cells (i.e., oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2), respectively. After injecting these NPs to nude mice bearing xenografted tumors, the biomarker expressions of the three markers can be identified by lifetime imaging. Their result showed excellent correlation with conventional immunohistochemical methods, indicating that lifetime imaging is a feasible approach for accurate quantification of disease markers. (Fig. 9a) . The limit of detection (LOD) for H 2 O 2 was determined to be 41.8 nmol L −1 by using NaCeF 4 :Er/Yb nanoprobes (Fig. 9b, c) . Based on the H 2 O 2 -responsive luminescence, we also demonstrated their application as homogeneous nanoprobes to detect uric acid (UA), since H 2 O 2 can be produced through the UA/uricase reaction ( Fig. 9d-f) . Accordingly, an LOD of 25.6 nmol L −1 was achieved for UA. Moreover, the concentrations of UA in serum samples determined by the NaCeF 4 :Er/Yb NPs were highly consistent with those measured by commercial kit, indicative of the assay's accuracy and reliability. These results revealed the great potential of Ln 3+ -doped NIR-II NPs for practical in vitro detection of disease markers.
BIOASSAY
To show the superiority of Ln ions also served as an emitter to produce UC emission at 1,180 nm. By virtue of the multiple emissions, the proposed NIR-II NPs can be utilized as ratiometric fluorescent H 2 O 2 sensor. Specifically, NaErF 4 :Ho@NaYF 4 NPs and organic chromophore probe IR1061 with strong absorption at 800-1,100 nm were encapsulated in polycaprolactone. In the absence of H 2 O 2 , the 980 nm emission (I 980 ) of Er 3+ was suppressed due to the strong absorption of IR1061. Nevertheless, H 2 O 2 may induce the destruction of IR1061, and thus weaken its absorption from 800 to 1,100 nm (Fig. 10a) . As a result, I 980 may gradually recover with increasing of the H 2 O 2 concentration. By contrast, the intensity of 1,180 nm emis- (Fig. 10b) . As a proof-of-concept experiment, they fabricated the microneedle patches based on the NaErF 4 :Ho@NaYF 4 NPs and IR1061 encapsulated polycaprolactone, which were applied for in vivo bioassay of H 2 O 2 in the inflammation site (Fig. 10c) . By taking advantage of low autofluorescence of the NIR-II emission, the PL images of the microneedle array can be clearly observed under the skin tissue of mice. Upon excitation at 1,530 nm, the PL signal of 1,180 nm was stable while the signal of 980 nm gradually increased as the evolution of inflammation with the continuous generation of H 2 O 2 (Fig. 10d) . According to the linear correlation between H 2 O 2 concentration and log(I 980 /I 1180 ), the concentration deviation of H 2 O 2 in the inflammatory site can be monitored from 0 to 12 h, which provides a feasible strategy for the quantitative detection of disease markers in vivo.
TEMPERATURE SENSING
Luminescent nanothermometers are widely applied in nanomedicine, physiology, medical diagnosis, and controllable hyperthermia treatment. Particularly, luminescent nanothermometers, which are suitable for contactless, non-invasive temperature measurement at sub-cellular level, have gained much attention when it comes to photothermal therapeutics. Moreover, high-resolution temperature sensing is highly desired not only at the cellular level but also for in vivo disease diagnosis. As mentioned above, the NIR-II emission can penetrate much deeper in the biological tissue than visible or NIR-I emissions. Thus, nanothermometers with temperaturedependent emission in the NIR-II region are ideal candidates for temperature sensing at the deep tissue level [117] . The energy gap between some Stark sublevels of Ln 3+ ions is very small (only few tens of wavenumbers), which is strongly thermally coupled. Therefore, small temperature variations may result in remarkable changes in their emitting intensity due to the population redistribution of the thermally coupled energy levels. Such temperature dependent population of excited electrons in different energy levels of Ln 3+ allows for ratiometric nanothermometry based on the intensity ratio of two emission bands. to 55°C with thermal sensitivity of~0.2%/°C. Carlos and co-workers proposed another kind of NIR-II nanothermometer based on Gd 2 O 3 :Nd NPs with temperature sensitivity of~0.23%/°C, which was assessed by the ratio between the integrated intensity of the transitions originated from the highest-and lowest-energy Stark sublevels from 4 F 3/2 of Nd 3+ [121] . Although some progress of NIR II nanothermometry was gained in the past decade, the sensitivity of such nanothermometers was relatively low.
To this regard, Ximendes et al. [118] designed LaF 3 :Nd@LaF 3 :Yb core/shell NPs as nanothermometers upon the excitation at 790 nm. In their work, the integrated intensity ratio of Yb 3+ and Nd 3+ NIR-II emissions was found to decrease with the temperature from 10 to 50°C. A 4-fold higher sensitivity (0.44%/°C) was achieved than that of LaF 3 :Nd/Yb core-only NPs. Moreover, the proposed nanothermometer enabled monitoring of the real-time subcutaneous temperature (Fig. 11) . After laserinduced heating, the subcutaneous temperature variation can be identified by the luminescent nanothermometry in a living animal (Fig. 11d) ions (820-840 nm) located in NIR-I region, which to some extent restricted their applications for temperature sensing in vivo. Very recently, several interesting studies were reported by employing the hybrid structured nanothermometers for sensitive temperature sensing [119, [124] [125] [126] [127] . Rodrí-guez et al. [119] designed a hybrid nanothermometer for subtissue temperature sensing (Fig. 12) . This hybrid nanothermometer was prepared following a double-emulsion encapsulation procedure by PbS/CdS/ZnS QDs as temperature-sensitve response unit and temperature-insensitive NaGdF 4 :Nd as internal standard unit for the deep tissue ratiometric thermal sensing (Fig. 12b) . The thermal sensitivity of the developed hybrid nanostructures was determined to be 2.5%/°C, which was one order of magnitude higher than that of the available NIR-I nanothermometers [128, 129] . Subsequently, Xu et al. [124] further improved the thermal sensitivity. Triplettriplet annihilation (TTA) dyad was modified on the surface of NaYF 4 :Nd to design an organic/inorganic hybrid ratiometric thermometer (Fig. 13) . The proposed organic/inorganic hybrid nanothermometer was applied to monitor the specific temperature variations and map the temperature distributions in the inflammatory mode, which exhibited high thermal sensitivity (~7.1%/°C) and resolution (~0.1°C). Nevertheless, the emission of TTA lay in the visible region, and double beam excitations combined with two detectors (PMT and InGaAs detectors) were required (Fig. 13a) . In addition, different attenuation through tissue of the emission signal of 540 nm from TTA and 1,060 nm from NaYF 4 :Nd might deteriorate the measurement accuracy in vivo. NPs provide unique opportunities for simultaneous multiplexed assay of different disease markers in deep tissue. Last but not the least, the prevailing in vivo imaging systems are equipped with a silicon-based chargecoupled device or complementary metal oxide semiconductor camera, which is unusable for NIR-II imaging studies. To demonstrate the potential bioapplications of Ln 3+ -doped NIR-II NPs, several research groups proposed different custom-built systems. As such, it is difficult to compare and evaluate the results from worldwide laboratories. There is a growing demand for the development of new-generation, but commercial cost-effective systems with highly NIR-sensitive detectors, which may significantly promote the clinical applications of NIR-II nanoprobes for sensitive bioimaging and bioassays in disease diagnosis. 
CONCLUSIONS AND PROSPECTS

